{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:48:35Z","timestamp":1779889715511,"version":"3.53.1"},"reference-count":17,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,6,8]],"date-time":"2015-06-08T00:00:00Z","timestamp":1433721600000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2015,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Interstitial lung disease (<jats:styled-content style=\"fixed-case\">ILD<\/jats:styled-content>) is one of the most common and devastated complication of polymyositis\/dermatomyositis (<jats:styled-content style=\"fixed-case\">PM<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">DM<\/jats:styled-content>). Several studies have focused on serum biomarkers for <jats:styled-content style=\"fixed-case\">ILD<\/jats:styled-content> in <jats:styled-content style=\"fixed-case\">PM<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">DM<\/jats:styled-content> patients; however, there have been no prospective studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To explore and compare the predictive value of four serum markers for the development of <jats:styled-content style=\"fixed-case\">ILD<\/jats:styled-content> in patients with <jats:styled-content style=\"fixed-case\">PM<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">DM<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>One hundred adult <jats:styled-content style=\"fixed-case\">PM<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">DM<\/jats:styled-content> patients were included in this prospective clinical study at baseline. Forty\u2010four <jats:styled-content style=\"fixed-case\">PM<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">DM<\/jats:styled-content> patients without <jats:styled-content style=\"fixed-case\">ILD<\/jats:styled-content> were followed up for 1 year. Fifty\u2010six <jats:styled-content style=\"fixed-case\">PM<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">DM<\/jats:styled-content> patients with <jats:styled-content style=\"fixed-case\">ILD<\/jats:styled-content> were treated and followed up for 2 months. Serum samples were analysed for the levels of Krebs von den Lungen\u20106 (<jats:styled-content style=\"fixed-case\">KL<\/jats:styled-content>\u20106), monocyte chemotactic protein\u20101 (<jats:styled-content style=\"fixed-case\">MCP<\/jats:styled-content>\u20101), surfactant protein\u2010<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">SP<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">SP<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Serum <jats:styled-content style=\"fixed-case\">KL<\/jats:styled-content>\u20106 (1542.8 \u00b1 760.8\u2009U\/mL) (<jats:italic>P<\/jats:italic> &lt; 0.001), <jats:styled-content style=\"fixed-case\">MCP<\/jats:styled-content>\u20101 (1870 \u00b1 1590\u2009pg\/mL) (<jats:italic>P<\/jats:italic> = 0.014), <jats:styled-content style=\"fixed-case\">SP<\/jats:styled-content>\u2010A (56 \u00b1 28\u2009ng\/mL) (<jats:italic>P<\/jats:italic> &lt; 0.001) and <jats:styled-content style=\"fixed-case\">SP<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">D<\/jats:styled-content> (230 \u00b1 196\u2009ng\/mL) (<jats:italic>P<\/jats:italic> &lt; 0.001) were significantly elevated in <jats:styled-content style=\"fixed-case\">PM<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">DM<\/jats:styled-content> patients with <jats:styled-content style=\"fixed-case\">ILD<\/jats:styled-content> compared with those in the patients without <jats:styled-content style=\"fixed-case\">ILD<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">KL<\/jats:styled-content>\u20106 429 \u00b1 105.8\u2009U\/mL; <jats:styled-content style=\"fixed-case\">MCP<\/jats:styled-content>\u20101 1349 \u00b1 1303\u2009pg\/mL; <jats:styled-content style=\"fixed-case\">SP<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content> 34 \u00b1 26\u2009ng\/mL; <jats:styled-content style=\"fixed-case\">SP<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">D<\/jats:styled-content> 96 \u00b1 63\u2009ng\/mL). In <jats:styled-content style=\"fixed-case\">PM<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">DM<\/jats:styled-content> patients without <jats:styled-content style=\"fixed-case\">ILD<\/jats:styled-content> who were followed up for 1 year, <jats:styled-content style=\"fixed-case\">KL<\/jats:styled-content>\u20106 presented the highest predictive value among single markers. In patients who were treated and followed up, <jats:styled-content style=\"fixed-case\">KL<\/jats:styled-content>\u20106 concentrations increased with the progression of <jats:styled-content style=\"fixed-case\">ILD<\/jats:styled-content> and decreased along with the improvement of <jats:styled-content style=\"fixed-case\">ILD<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Considering the ability of <jats:styled-content style=\"fixed-case\">KL<\/jats:styled-content>\u20106 for predicting the onset of <jats:styled-content style=\"fixed-case\">ILD<\/jats:styled-content> and monitoring the treatment response of <jats:styled-content style=\"fixed-case\">ILD<\/jats:styled-content> in <jats:styled-content style=\"fixed-case\">PM<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">DM<\/jats:styled-content> patients, it may be of great significance for clinical practice, and the prognosis of patients may be substantially improved if serum <jats:styled-content style=\"fixed-case\">KL<\/jats:styled-content>\u20106 was regularly monitored.<\/jats:p><\/jats:sec>","DOI":"10.1111\/imj.12754","type":"journal-article","created":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T17:36:24Z","timestamp":1427909784000},"page":"641-647","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Predictive value of serum markers for the development of interstitial lung disease in patients with polymyositis and dermatomyositis: a comparative and prospective study"],"prefix":"10.1111","volume":"45","author":[{"given":"F.","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Rheumatology China\u2010Japan Friendship Hospital  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology China\u2010Japan Friendship Hospital  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Shu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology China\u2010Japan Friendship Hospital  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Rheumatology China\u2010Japan Friendship Hospital  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Rheumatology China\u2010Japan Friendship Hospital  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology China\u2010Japan Friendship Hospital  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,6,8]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"414","article-title":"Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato\/polymyositis","volume":"26","author":"Kum\u00e1novics G","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.59.4.257"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.6.632"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-2103-8"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.2.ats3-00"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197502132920706"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-013-0359-6"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2011.02459.x"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3761"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1371527"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2007.01.003"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2006.00809.x"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mn.7800193"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3003.1999.14b23.x"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.resinv.2012.02.001"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.165.3.2107134"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.11.1268"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fimj.12754","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.12754","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T17:13:13Z","timestamp":1695489193000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/imj.12754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["10.1111\/imj.12754"],"URL":"https:\/\/doi.org\/10.1111\/imj.12754","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"2014-10-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-03-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-06-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}